Jul 13, 2026 05:13PM
Jun 23, 2026 06:04AM
May 27, 2026 08:01PM
May 12, 2026 04:06PM
May 7, 2026 06:29AM
Mar 17, 2026 07:00AM
Mar 12, 2026 07:05AM Gyre Therapeutics (GYRE) Misses Q4 EPS by 7c
Mar 2, 2026 11:58AM
Jan 5, 2026 07:13AM
Nov 7, 2025 04:13PM
Oct 16, 2025 06:43AM
Oct 10, 2025 05:04AM
Aug 26, 2025 07:10AM
Aug 11, 2025 04:46PM Gyre Therapeutics (GYRE) Misses Q2 EPS by 2c
Jun 10, 2025 07:07AM
May 23, 2025 05:53AM
May 22, 2025 04:03PM
May 22, 2025 04:03PM
May 9, 2025 04:48PM
Mar 31, 2025 07:02AM
Mar 27, 2025 07:00AM Gyre Therapeutics (GYRE) Announces Publication of Protocol for Phase 3 Trial Evaluating F351
Mar 17, 2025 05:26PM
Jan 6, 2025 07:01AM
Nov 14, 2024 04:49PM
Nov 13, 2024 05:07PM
Aug 13, 2024 07:22AM
Aug 8, 2024 04:09PM
Jul 2, 2024 04:06PM Gyre Therapeutics (GYRE) Announces China’s NMPA Approval of Avatrombopag Maleate Tablets

423,264 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All